Annual Retained Earnings
-$691.34 M
-$28.60 M-4.32%
December 31, 2023
Summary
- As of February 8, 2025, VYNE annual retained earnings is -$691.34 million, with the most recent change of -$28.60 million (-4.32%) on December 31, 2023.
- During the last 3 years, VYNE annual retained earnings has fallen by -$125.14 million (-22.10%).
- VYNE annual retained earnings is now -4208.19% below its all-time high of -$16.05 million, reached on December 31, 2015.
Performance
VYNE Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$719.15 M
-$12.16 M-1.72%
September 30, 2024
Summary
- As of February 8, 2025, VYNE quarterly retained earnings is -$719.15 million, with the most recent change of -$12.16 million (-1.72%) on September 30, 2024.
- Over the past year, VYNE quarterly retained earnings has dropped by -$12.16 million (-1.72%).
- VYNE quarterly retained earnings is now -2288.01% below its all-time high of -$30.11 million, reached on December 31, 2016.
Performance
VYNE Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
VYNE Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.3% | -1.7% |
| 3 y3 years | -22.1% | -8.5% |
| 5 y5 years | -524.9% | -8.5% |
VYNE Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.1% | at low | -13.3% | at low |
| 5 y | 5-year | -275.0% | at low | -290.1% | at low |
| alltime | all time | -4208.2% | at low | -2288.0% | at low |
VYNE Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$719.15 M(+1.7%) |
| Jun 2024 | - | -$706.99 M(+1.3%) |
| Mar 2024 | - | -$697.59 M(+0.9%) |
| Dec 2023 | -$691.34 M(+4.3%) | -$691.34 M(+0.9%) |
| Sep 2023 | - | -$685.15 M(+1.0%) |
| Jun 2023 | - | -$678.56 M(+1.5%) |
| Mar 2023 | - | -$668.51 M(+0.9%) |
| Dec 2022 | -$662.74 M(+3.6%) | -$662.74 M(+1.5%) |
| Sep 2022 | - | -$652.79 M(+1.5%) |
| Jun 2022 | - | -$643.33 M(+1.3%) |
| Mar 2022 | - | -$634.86 M(-0.7%) |
| Dec 2021 | -$639.52 M(+13.0%) | -$639.52 M(+1.8%) |
| Sep 2021 | - | -$627.96 M(+3.5%) |
| Jun 2021 | - | -$606.67 M(+3.4%) |
| Mar 2021 | - | -$586.75 M(+3.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | -$566.20 M(+207.1%) | -$566.20 M(+4.3%) |
| Sep 2020 | - | -$543.01 M(+4.8%) |
| Jun 2020 | - | -$518.30 M(+47.7%) |
| Mar 2020 | - | -$350.86 M(+90.3%) |
| Dec 2019 | -$184.34 M(+66.6%) | -$184.34 M(+13.2%) |
| Sep 2019 | - | -$162.84 M(+11.5%) |
| Jun 2019 | - | -$145.99 M(+12.7%) |
| Mar 2019 | - | -$129.51 M(+17.1%) |
| Dec 2018 | -$110.64 M(+86.9%) | -$110.64 M(+18.9%) |
| Sep 2018 | - | -$93.04 M(+16.0%) |
| Jun 2018 | - | -$80.19 M(+11.6%) |
| Mar 2018 | - | -$71.85 M(+21.4%) |
| Dec 2017 | -$59.19 M(+96.5%) | -$59.19 M(+18.6%) |
| Sep 2017 | - | -$49.91 M(+65.7%) |
| Dec 2016 | -$30.11 M(+87.7%) | -$30.11 M |
| Dec 2015 | -$16.05 M | - |
FAQ
- What is VYNE Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for VYNE Therapeutics?
- What is VYNE Therapeutics annual retained earnings year-on-year change?
- What is VYNE Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for VYNE Therapeutics?
- What is VYNE Therapeutics quarterly retained earnings year-on-year change?
What is VYNE Therapeutics annual retained earnings?
The current annual retained earnings of VYNE is -$691.34 M
What is the all time high annual retained earnings for VYNE Therapeutics?
VYNE Therapeutics all-time high annual retained earnings is -$16.05 M
What is VYNE Therapeutics annual retained earnings year-on-year change?
Over the past year, VYNE annual retained earnings has changed by -$28.60 M (-4.32%)
What is VYNE Therapeutics quarterly retained earnings?
The current quarterly retained earnings of VYNE is -$719.15 M
What is the all time high quarterly retained earnings for VYNE Therapeutics?
VYNE Therapeutics all-time high quarterly retained earnings is -$30.11 M
What is VYNE Therapeutics quarterly retained earnings year-on-year change?
Over the past year, VYNE quarterly retained earnings has changed by -$12.16 M (-1.72%)